WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone. Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic. Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid. The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity. |
Two US Navy sailors arrested on charges tied to national security and ChinaAlarm over 'strange' illness that has killed four and sickened dozens more in NigeriaChina floods: Beijing records heaviest rainfall in at least 140 yearsIsraeli parliament approves amended 2024 budget to fund Gaza warRussia's presidential vote starts final day with accusations of Kyiv sabotageChina news: July exports tumble by double digits, adding to pressure to shore up flagging economyHong Kong down to earth designer Niko Leung crafts ceramics from construction wasteDoes Donald Trump have presidential immunity? Thousands of Russians join NavalnyChina Taiwan update: War